AME vs EMR
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AME · AMETEK$222.90 ▼ 3.57%
EMR · Emerson Electric$150.93 ▼ 4.23%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AME +14.9%
- EMR +18.7%
Head to head
| Metric | AME | EMR |
|---|---|---|
| Price | $222.90 | $150.93 |
| Change today | ▼ 3.57% | ▼ 4.23% |
| Market cap | $51.11B | $82.80B |
| Return, 3 months | -7.9% | -4.2% |
| Return, year to date | +9.1% | +15.0% |
| Return, 1 year | +15.0% | +19.0% |
| P/E (TTM) | 31.4 | 31.5 |
| P/B | 4.4 | 4.0 |
| P/E percentile vs own 5y | 68th | 85th |
| Dividend yield | 0.60% | 1.47% |
| Revenue growth (YoY, latest qtr) | +17.3% | +7.1% |
| Net profit growth (YoY) | +14.8% | +22.3% |
| Gross margin | 36.4% | 53.4% |
| Operating margin | 26.0% | 21.2% |
| Net margin | 19.9% | 14.2% |
| Return on equity | 14.7% | 13.1% |
| Analyst target vs. price | +28.7% | +22.5% |
| Analyst buy share | 64% | 69% |
| RSI (14) | 35 | 35 |
| 30-day volatility | 37.7% | 32.8% |
| Max drawdown, 1 year | -13.7% | -23.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- EMR is the largest of the group by market value.
- EMR has returned the most over the past year.
- AME carries the lowest trailing P/E.
- EMR pays the highest dividend yield.
- AME is growing revenue fastest.
- AME keeps the most profit per dollar of sales.
- EMR has been the calmest stock over the last 30 days.